Hunan Warrant Pharmaceutical (SHA:688799) received the drug registration certificate from China's National Medical Products Administration for loxoprofen sodium patches, according to a Tuesday filing with the Shanghai bourse.
The patches are indicated for osteoarthritis, muscle pain, or trauma-induced swelling or pain.